The UK’s dedicated event that offers a comprehensive program on the latest innovations in imaging diagnosis and treatment.
With headquarters in Cambridgeshire, UK, Tristel is the only company in the world to combine its proprietary chlorine dioxide technology (ClO2) with innovative packaging to deliver high-performance disinfectants for medical instruments and surfaces.
The TristelTM portfolio comprises chlorine dioxide-based high-level disinfectants for semi-critical, non-lumened and single-lumened medical instruments, such as transvaginal and transrectal ultrasound probes, nasendoscopes, transoephagel echocardiography (TOE) probes, laryngoscopes, manometry catheters, cystoscopes and ophthalmic instruments.
Established in 2003, the Tristel Trio Wipes System is today tried and trusted and has been used in more than 45 countries for over 16 years. It is the world’s most widely approved, validated and used wipes system for medical devices, compliant with all the latest European legal requirements for medical devices.
The first stage in the decontamination process is performed by the Tristel Pre-Clean Wipe, a non-woven wipe impregnated with a triple enzymatic detergent featuring excellent cleaning performance.
The Tristel Sporicidal Wipe and Activator Foam represent the second stage in the decontamination process featuring a uniform contact time of 30 seconds. This is the same contact time used in each of the tests required by BS EN 14885:2018. The Wipe and the Foam combine to generate Tristel’s proprietary chlorine dioxide chemistry, with proven efficacy against microorganisms of concern including Human Papillomavirus (HPV). Type 16 and 18 of this virus are extensively documented as causative agents of cancers of the cervix and head and neck. The virus is therefore of special concern within gynaecological and head and neck procedures, as it may be a cause of potential cross-contamination between device and patient/healthcare workers.
Published literature reports that not all high-level disinfectants included in worldwide decontamination guidelines for endocavity ultrasound and endoscope disinfection demonstrate effectiveness against HPV type 16 and 18.
The Tristel Sporicidal Wipe is recognised as a high-level disinfectant in leading guidelines and has also been proven effective against HPV type 18 in a study undertaken by Dr. Craig Meyers, of Penn State Hershey Medical Center. His work involved suspension tests using the published protocol developed by him. This was employed in the work published by Dr. Craig Meyers in the Journal of Antimicrobial Chemotherapy comparing alcohols (ethanol, isopropanol), aldehydes (GTA, OPA), phenol and oxidisers (PAA-silver, hyperchlorite). In this study, only oxidising chemistries were found to be effective – the same chemistry employed within the Tristel Sporicidal Wipe. More recent work has been conducted by Dr. Craig Meyers testing the Tristel Sporicidal Wipe on real-life devices (endocavity ultrasound probe and nasendoscope) against HPV 16 and 18 representing a significant advance on earlier published work. At the time of writing, Tristel are the first to perform testing on real-life devices. Dr. Craig Meyer’s ground-breaking work is intended for peer-review and publication shortly.
The last step in the decontamination process features the Tristel Rinse Wipe. Device reprocessing requires bacteria-free rinsing according to BS EN ISO 15883. Other wipes pre-impregnated with reverse osmosis (RO) water, but not sterilised, spoil with microbial growth and pose a patient risk. The Tristel Trio Wipes System is approved by more than 40 manufacturers of nasendoscopes, laryngoscopes, TOE probes, intracavity ultrasound probes, manometry catheters and ophthalmic instruments. Paper-based or digital traceability is available. The widely-used quality audit trail record book documents each disinfection event with pen and paper. The 3T Traceability System digitalises this process for a more efficient, accurate and smart approach to traceability. The Tristel Trio Wipes System is featured in many peer-reviewed publications, guidelines and standard operating procedures worldwide. Click here to find out more!
CacheTM is Tristel’s new cleaning and disinfection brand for hospital surfaces.
JET is a powerful sporicidal disinfectant foam that can be used on medical device surfaces located near the patient. JET is also a powerful cleaner destroying RNA and DNA in seconds. Its cleaning efficacy meets the requirements of a medical instrument cleaner, effectively reducing levels of protein and carbohydrate. JET is the best safeguard for patients and staff wherever the risks of infection are highest. JET is designed for use in areas such as patient wards, isolation wards, operating theatres, intensive care units, oncology wards and neonatal wards.
JET features 1 uniform contact time of 1 minute, 1st level of compliance with all applicable EN standards, 1 active ingredient (chlorine dioxide), resulting in 1 disinfectant for all surfaces.
JET is built upon the same core chlorine dioxide technology as Tristel medical instrument disinfectant products, but specially adapted for surface disinfection where cleaning and biofilm destruction are so important. Chlorine dioxide is widely regarded as one of the most effective disinfectants for biofilm removal and prevention. JET delivers chlorine dioxide as a foam. It creates no aerosols when used.
Efficacy with the standard wipe in EN 16615 means JET can be used with any sustainably sourced wipe, avoiding the use and waste of plastic wipes.
Find out more on Tristel’s website!